Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimberly Clark Corp (KMB) vs Medpace Holdings Inc (MEDP) Price & Performance

Kimberly Clark CorpTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Kimberly Clark Corp vs Medpace Holdings Inc — how do they compare? Kimberly Clark Corp trades at $109.38 (market cap $36.11B), while Medpace Holdings Inc trades at $600 (market cap $16.90B). The key difference: Kimberly Clark Corp is far larger — about 2.1× Medpace Holdings Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.

KMBMEDP
Market Cap
$36.11B$16.90B
Sector
Consumer StaplesTechnology
52-Week High
$134.81$620.59
52-Week Low
$93.05$393.42
Enterprise Value
$41.67B$16.52B
Dividend Yield
4.72%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kimberly Clark Corp

Kimberly-Clark (KMB) trades at $109.47, up 1.34% today, with a neutral technical signal and bearish moving averages. Recent Q2 2026 earnings missed estimates due to China diaper disruptions and a distribution center fire, though gross margin expanded. The company maintains a strong dividend yield of 4.7% and an A credit rating. Analyst consensus is a $113.20 price target with 29% buy ratings, but near-term headwinds include softer consumer demand and inventory adjustments.

Outlook remains cautious with 2026 guidance trimmed; the stock offers value at a forward P/E of 14.6x and robust cash flow, but risks from China market volatility and input cost pressures persist. Institutional interest is mixed, with recent filings showing both new positions and trims. Long-term prospects hinge on innovation and productivity gains offsetting cyclical challenges.

Medpace Holdings Inc

MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.

Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kimberly Clark Corp

With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Read more on KMB

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP